Cullinan Therapeutics, Inc. (CGEM): Shares Outstanding
60.24M
As of 2025-12-31
64.35M
As of 2026-06-30
+9.6%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 60.24M | +3.0% | 2026-03-10, Balance as of period end |
| 2024-12-31 | 58.51M | +36.4% | 2026-03-10, Balance as of period end |
| 2023-12-31 | 42.90M | -6.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 45.80M | +3.4% | 2024-03-14, Balance as of period end |
| 2021-12-31 | 44.29M | n/c | 2023-03-09, Balance as of period end |
| 2020-12-31 | 29.83M | n/a | 2022-03-17, Balance as of period end |